Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile.

Barf T, Covey T, Izumi R, van de Kar B, Gulrajani M, van Lith B, van Hoek M, de Zwart E, Mittag D, Demont D, Verkaik S, Krantz F, Pearson PG, Ulrich R, Kaptein A.

J Pharmacol Exp Ther. 2017 Nov;363(2):240-252. doi: 10.1124/jpet.117.242909. Epub 2017 Sep 7.

PMID:
28882879
2.

Structure-based lead identification of ATP-competitive MK2 inhibitors.

Barf T, Kaptein A, de Wilde S, van der Heijden R, van Someren R, Demont D, Schultz-Fademrecht C, Versteegh J, van Zeeland M, Seegers N, Kazemier B, van de Kar B, van Hoek M, de Roos J, Klop H, Smeets R, Hofstra C, Hornberg J, Oubrie A.

Bioorg Med Chem Lett. 2011 Jun 15;21(12):3818-22. doi: 10.1016/j.bmcl.2011.04.018. Epub 2011 Apr 16.

PMID:
21565500
3.

Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.

van Straten NC, van Berkel TH, Demont DR, Karstens WJ, Merkx R, Oosterom J, Schulz J, van Someren RG, Timmers CM, van Zandvoort PM.

J Med Chem. 2005 Mar 24;48(6):1697-700.

PMID:
15771412
4.

Controlled biological production of emboli.

Demont D, Marr EM, Irwin JW.

Bibl Anat. 1967;9:181-6. No abstract available.

PMID:
6029864
5.

Microcirculation of the inner ear.

Irwin JW, Marr E, Alcaide DC, Demont D.

Bibl Anat. 1965;7:50-4. No abstract available.

PMID:
5860783

Supplemental Content

Loading ...
Support Center